FDA issued a Warning Letter to Morton Grove Pharmaceuticals, Inc. on 2/17/2017 for a previous inspection.
483 Morton Grove Pharmaceuticals Oct 2019
483 Morton Grove Pharmaceuticals Oct 2019
$119 - Not in Stock
FDA investigators audited the Morton Grove Pharmaceuticals - Morton Grove, IL, United States facility and issued inspectional observations (via FDA 483) on 31 Oct 2019.
